2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on…

By S. Grundy, N. Stone, Alison L. Bailey, Craig T. Beam, K. Birtcher, R. Blumenthal, L. Braun, S. D. de Ferranti, Joseph Faiella-Tommasino, D. Forman and 14 more. Journal of the American College of Cardiology, 2019

5,063 citations recorded by the source corpus.

Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [‡‡‡][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD,

Subfields: Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/39be996639629566fb5bea3b88f10bac3447c587

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Endocrinology, Diabetes and Metabolism

In Surgery

Citations in the corpus

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021, background): “20,157 Subtracting directly measured LDL-C from non-HDL-C provides a crude estimate of remnant cholesterol content 78 but includes cholesterol in TRL not yet processed to remnants.”
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association (2023, background): “66 In hypertension, a therapeutic goal for all patients is 130/80 mm Hg. ACE inhibitors/ARBs should be prioritized in patients with CVD and CKD or diabetes for cardiovascular and renal benefits.”